Overview and countermeasures of cancer burden in China

Yian Wang; Qijia Yan; Chunmei Fan; Yongzhen Mo; Yumin Wang; Xiayu Li; Qianjin Liao; Can Guo; Guiyuan Li; Zhaoyang Zeng; Wei Xiong; He Huang

doi:10.1007/s11427-022-2240-6

Overview and countermeasures of cancer burden in China

Sci China Life Sci. 2023 Nov;66(11):2515-2526. doi: 10.1007/s11427-022-2240-6. Epub 2023 Apr 13.

Authors

Yian Wang^{1

2

3}, Qijia Yan⁴, Chunmei Fan², Yongzhen Mo², Yumin Wang⁴, Xiayu Li³, Qianjin Liao¹, Can Guo², Guiyuan Li^{1

2

3}, Zhaoyang Zeng^{1

2}, Wei Xiong^{5

6

7}, He Huang^{8

9

10}

Affiliations

¹ NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410078, China.
² Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, 410078, China.
³ Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Disease Genome Research Center, The Third Xiangya Hospital, Central South University, Changsha, 410078, China.
⁴ Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, 410078, China.
⁵ NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410078, China. xiongwei@csu.edu.cn.
⁶ Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, 410078, China. xiongwei@csu.edu.cn.
⁷ Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Disease Genome Research Center, The Third Xiangya Hospital, Central South University, Changsha, 410078, China. xiongwei@csu.edu.cn.
⁸ NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410078, China. huanghe@csu.edu.cn.
⁹ Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, 410078, China. huanghe@csu.edu.cn.
¹⁰ Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Disease Genome Research Center, The Third Xiangya Hospital, Central South University, Changsha, 410078, China. huanghe@csu.edu.cn.

Abstract

Cancer is one of the leading causes of human death worldwide. Treatment of cancer exhausts significant medical resources, and the morbidity and mortality caused by cancer is a huge social burden. Cancer has therefore become a serious economic and social problem shared globally. As an increasingly prevalent disease in China, cancer is a huge challenge for the country's healthcare system. Based on recent data published in the Journal of the National Cancer Center on cancer incidence and mortality in China in 2016, we analyzed the current trends in cancer incidence and changes in cancer mortality and survival rate in China. And also, we examined several key risk factors for cancer pathogenesis and discussed potential countermeasures for cancer prevention and treatment in China.

Keywords: China; cancer; countermeasures; incidence; mortality; statistics; survival.

Publication types

Review

MeSH terms

China / epidemiology
Humans
Incidence
Neoplasms* / epidemiology
Neoplasms* / prevention & control
Risk Factors
Survival Rate